← Back to headlines
Morgan Stanley Adjusts Gilead Sciences Outlook Ahead of Q1 Earnings
Morgan Stanley has adjusted its outlook for Gilead Sciences, Inc. in anticipation of the company's first-quarter earnings report.
17 Apr, 13:44 — 17 Apr, 13:44
Sources
Showing 1 of 1 sources
